# Essential Properties Realty Trust, Inc.: financial statements, quarterly

EPRT · NYSE · CIK 1728951 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/eprt.md) · [Financials](/companies/eprt/financials.md) · [Filings](/companies/eprt/filings.md) · [Insiders](/companies/eprt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/eprt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [97.7 d](/filings/0001728951-26-000008.md) | [104](/filings/0001728951-25-000082.md) | [109](/filings/0001728951-25-000148.md) | [117](/filings/0001728951-25-000177.md) | [120 d](/filings/0001728951-26-000008.md) | [129](/filings/0001728951-26-000029.md) | [137](/filings/0001728951-26-000052.md) | [145](/filings/0001728951-26-000071.md) | [150 d](/filings/0001728951-26-000008.md) | [159](/filings/0001728951-26-000029.md) | [162](/filings/0001728951-26-000052.md) | [169](/filings/0001728951-26-000071.md) |
| Operating income | $m | [64.6 d](/filings/0001728951-26-000008.md) | [62.4](/filings/0001728951-25-000082.md) | [66.8](/filings/0001728951-25-000148.md) | [69.9](/filings/0001728951-25-000177.md) | [79.1 d](/filings/0001728951-26-000008.md) | [79.6](/filings/0001728951-26-000029.md) | [87.8](/filings/0001728951-26-000052.md) | [93.7](/filings/0001728951-26-000071.md) | [98.8 d](/filings/0001728951-26-000008.md) | [89.6](/filings/0001728951-26-000029.md) | [104](/filings/0001728951-26-000052.md) | [94.5](/filings/0001728951-26-000071.md) |
| Interest expense | $m | [15.8 d](/filings/0001728951-24-000026.md) | [15.6](/filings/0001728951-24-000073.md) | [17.4](/filings/0001728951-25-000148.md) | [21.6](/filings/0001728951-25-000177.md) | [24.0 d](/filings/0001728951-26-000008.md) | [23.8](/filings/0001728951-26-000029.md) | [25.0](/filings/0001728951-26-000052.md) | [28.3](/filings/0001728951-26-000071.md) | [30.9 d](/filings/0001728951-26-000008.md) | [29.9](/filings/0001728951-26-000029.md) | [30.3](/filings/0001728951-26-000052.md) | [34.2](/filings/0001728951-26-000071.md) |
| Income tax | $m | [0.2 d](/filings/0001728951-26-000008.md) | [0.2](/filings/0001728951-25-000082.md) | [0.2](/filings/0001728951-25-000148.md) | [0.2](/filings/0001728951-25-000177.md) | [0.2 d](/filings/0001728951-26-000008.md) | [0.2](/filings/0001728951-26-000029.md) | [0.2](/filings/0001728951-26-000052.md) | [0.2](/filings/0001728951-26-000071.md) | [0.2 d](/filings/0001728951-26-000008.md) | [0.2](/filings/0001728951-26-000029.md) | [0.6](/filings/0001728951-26-000052.md) | [0.2](/filings/0001728951-26-000071.md) |
| Net income | $m | [49.1 d](/filings/0001728951-26-000008.md) | [47.0](/filings/0001728951-25-000082.md) | [51.5](/filings/0001728951-25-000148.md) | [49.1](/filings/0001728951-25-000177.md) | [55.4 d](/filings/0001728951-26-000008.md) | [56.1](/filings/0001728951-26-000029.md) | [63.2](/filings/0001728951-26-000052.md) | [65.6](/filings/0001728951-26-000071.md) | [68.1 d](/filings/0001728951-26-000008.md) | [59.8](/filings/0001728951-26-000029.md) | [74.3](/filings/0001728951-26-000052.md) | [60.2](/filings/0001728951-26-000071.md) |
| Diluted EPS | $ per share | not reported | [0.28](/filings/0001728951-25-000082.md) | [0.29](/filings/0001728951-25-000148.md) | [0.27](/filings/0001728951-25-000177.md) | not reported | [0.29](/filings/0001728951-26-000029.md) | [0.32](/filings/0001728951-26-000052.md) | [0.33](/filings/0001728951-26-000071.md) | not reported | [0.28](/filings/0001728951-26-000029.md) | [0.34](/filings/0001728951-26-000052.md) | [0.27](/filings/0001728951-26-000071.md) |
| Basic EPS | $ per share | not reported | [0.28](/filings/0001728951-25-000082.md) | [0.29](/filings/0001728951-25-000148.md) | [0.28](/filings/0001728951-25-000177.md) | not reported | [0.30](/filings/0001728951-26-000029.md) | [0.32](/filings/0001728951-26-000052.md) | [0.33](/filings/0001728951-26-000071.md) | not reported | [0.28](/filings/0001728951-26-000029.md) | [0.34](/filings/0001728951-26-000052.md) | [0.28](/filings/0001728951-26-000071.md) |

- Revenue: us-gaap:Revenues
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [39.8](/filings/0001728951-26-000008.md) | [79.2](/filings/0001728951-25-000082.md) | [23.6](/filings/0001728951-25-000148.md) | [32.7](/filings/0001728951-25-000177.md) | [40.7](/filings/0001728951-26-000008.md) | [47.0](/filings/0001728951-26-000029.md) | [20.8](/filings/0001728951-26-000052.md) | [23.8](/filings/0001728951-26-000071.md) | [60.2](/filings/0001728951-26-000071.md) | [15.2](/filings/0001728951-26-000029.md) | [126](/filings/0001728951-26-000052.md) | [25.2](/filings/0001728951-26-000071.md) |
| Total assets | $m | [4,768](/filings/0001728951-25-000031.md) | [5,013](/filings/0001728951-24-000073.md) | [5,267](/filings/0001728951-24-000130.md) | [5,532](/filings/0001728951-24-000166.md) | [5,799](/filings/0001728951-26-000008.md) | [6,057](/filings/0001728951-25-000082.md) | [6,290](/filings/0001728951-25-000148.md) | [6,610](/filings/0001728951-25-000177.md) | [6,863](/filings/0001728951-26-000071.md) | [7,153](/filings/0001728951-26-000029.md) | [7,490](/filings/0001728951-26-000052.md) | [7,690](/filings/0001728951-26-000071.md) |
| Total liabilities | $m | [1,781](/filings/0001728951-25-000031.md) | [1,766](/filings/0001728951-24-000073.md) | [2,015](/filings/0001728951-24-000130.md) | [2,330](/filings/0001728951-24-000166.md) | [2,227](/filings/0001728951-26-000008.md) | [2,234](/filings/0001728951-25-000082.md) | [2,452](/filings/0001728951-25-000148.md) | [2,766](/filings/0001728951-25-000177.md) | [2,655](/filings/0001728951-26-000071.md) | [2,756](/filings/0001728951-26-000029.md) | [3,038](/filings/0001728951-26-000052.md) | [3,105](/filings/0001728951-26-000071.md) |
| Long-term debt | $m | [1,680](/filings/0001728951-24-000026.md) | [1,680](/filings/0001728951-24-000073.md) | [1,925](/filings/0001728951-24-000130.md) | [2,210](/filings/0001728951-24-000166.md) | [2,130](/filings/0001728951-25-000031.md) | [2,130](/filings/0001728951-25-000082.md) | [2,330](/filings/0001728951-25-000148.md) | [2,650](/filings/0001728951-25-000177.md) | [2,530](/filings/0001728951-26-000008.md) | [2,630](/filings/0001728951-26-000029.md) | [2,930](/filings/0001728951-26-000052.md) | [2,991](/filings/0001728951-26-000071.md) |
| Shareholders' equity | $m | [2,979](/filings/0001728951-25-000031.md) | [3,239](/filings/0001728951-24-000073.md) | [3,244](/filings/0001728951-24-000130.md) | [3,193](/filings/0001728951-24-000166.md) | [3,564](/filings/0001728951-26-000008.md) | [3,815](/filings/0001728951-25-000082.md) | [3,830](/filings/0001728951-25-000148.md) | [3,837](/filings/0001728951-25-000177.md) | [4,200](/filings/0001728951-26-000071.md) | [4,389](/filings/0001728951-26-000029.md) | [4,408](/filings/0001728951-26-000052.md) | [4,541](/filings/0001728951-26-000071.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [72.6 d](/filings/0001728951-26-000008.md) | [66.8](/filings/0001728951-25-000082.md) | [81.1 d](/filings/0001728951-25-000148.md) | [73.5 d](/filings/0001728951-25-000177.md) | [87.1 d](/filings/0001728951-26-000008.md) | [77.2](/filings/0001728951-26-000029.md) | [99.8 d](/filings/0001728951-26-000052.md) | [99.0 d](/filings/0001728951-26-000071.md) | [105 d](/filings/0001728951-26-000008.md) | [99.8](/filings/0001728951-26-000029.md) | [110 d](/filings/0001728951-26-000052.md) | [118 d](/filings/0001728951-26-000071.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [43.9 d](/filings/0001728951-26-000008.md) | [47.2](/filings/0001728951-25-000082.md) | [50.2 d](/filings/0001728951-25-000148.md) | [51.1 d](/filings/0001728951-25-000177.md) | [51.1 d](/filings/0001728951-26-000008.md) | [55.6](/filings/0001728951-26-000029.md) | [58.7 d](/filings/0001728951-26-000052.md) | [59.8 d](/filings/0001728951-26-000071.md) | [59.8 d](/filings/0001728951-26-000008.md) | [65.4](/filings/0001728951-26-000029.md) | [67.6 d](/filings/0001728951-26-000052.md) | [70.2 d](/filings/0001728951-26-000071.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividends

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [146](/filings/0001728951-24-000073.md) | [152](/filings/0001728951-24-000130.md) | [157](/filings/0001728951-24-000166.md) | [169](/filings/0001728951-25-000082.md) | [178](/filings/0001728951-25-000148.md) | [180](/filings/0001728951-25-000177.md) | [191](/filings/0001728951-26-000029.md) | [200](/filings/0001728951-26-000052.md) | [200](/filings/0001728951-26-000071.md) | [212](/filings/0001728951-26-000029.md) | [218](/filings/0001728951-26-000052.md) | [219](/filings/0001728951-26-000071.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 220,275,169 at 2026-10-21, from the cover of the [10-Q filed 2026-10-21](/filings/0001728951-26-000071.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.